Italia markets closed

BioGaia AB (publ) (0GTN.IL)

IOB - IOB Prezzo differito. Valuta in SEK.
Aggiungi a watchlist
115,19+0,18 (+0,16%)
Alla chiusura: 07:05PM BST

BioGaia AB (publ)

Kungsbroplan 3
Stockholm 112 27
Sweden
46 8 55 52 93 00
https://www.biogaia.com

Settore/iHealthcare
SettoreDrug Manufacturers - Specialty & Generic
Impiegati a tempo pieno212

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Peter Rothschild M.Sc. Econ., MBAFounder & Chairman1,3MN/D1950
Mr. Alexander Kotsinas M.Sc. (Eng.).Exec. VP & CFO2,98MN/D1967
Ms. Theresa P. AgnewCEO & PresN/DN/DN/D
Ludvig MilessonChief Operating OfficerN/DN/D1977
Mr. Gianfranco GromponeChief Scientific Officer and VP of R&DN/DN/D1975
Ms. Caroline MoforsChief Legal OfficerN/DN/D1972
Ms. Linda HagglundVP of MarketingN/DN/D1973
Ms. Angelika KjelldorffChief HR OfficerN/DN/D1969
Sebastian HeimforsVP & Chief Commercial OfficerN/DN/D1974
Jonathan GromarkSustainability Mang.N/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in SEK.

Descrizione

BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylori–the gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Governance aziendale

L'ISS Governance QualityScore di BioGaia AB (publ) al 1 ottobre 2023 è 9. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 7; diritti degli azionisti: 8; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.